{{Unreferenced|date=December 2009}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 464216628
| IUPAC_name = 1-[10-(2-dimethylaminopropyl)-10''H''-phenothiazin-2-yl]propan-1-one
| image = Propiomazine.svg
| width = 222

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|CONS|propiomazine}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| routes_of_administration = [[Intramuscular injection|IM]], [[intravenous therapy|IV]]

<!--Identifiers-->
| IUPHAR_ligand = 7284
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 362-29-8
| ATC_prefix = N05
| ATC_suffix = CM06
| PubChem = 4940
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00777
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4771
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 242Z0PM79Y
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02361
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 8491
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201210

<!--Chemical data-->
| C=20 | H=24 | N=2 | O=1 | S=1
| molecular_weight = 340.483 g/mol
| smiles = O=C(c2cc1N(c3c(Sc1cc2)cccc3)CC(N(C)C)C)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C20H24N2OS/c1-5-18(23)15-10-11-20-17(12-15)22(13-14(2)21(3)4)16-8-6-7-9-19(16)24-20/h6-12,14H,5,13H2,1-4H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UVOIBTBFPOZKGP-UHFFFAOYSA-N
}}

'''Propiomazine''' ('''Largon''', '''Propavan''', '''Indorm''', '''Serentin''', '''Dorevane''', '''Dorevan''') is an [[antihistamine]] blocking H1 receptors. It is used to treat [[insomnia]], and to produce sleepiness or drowsiness and to relieve anxiety before or during [[surgery]] or other procedures and in combination with [[analgetic]]s also during [[Childbirth|labor]]. Propiomazine is a [[phenothiazine]], but is not used as a [[neuroleptic]] because it does not block [[dopamine receptors]] well.

==Mechanism of action==
Propiomazine is an antagonist at types 1, 2, and 4 dopamine receptors, serotonin (5-HT) receptor types 2A and 2C, muscarinic receptors 1 through 5, alpha(1)-receptors, and histamine H1-receptors. Propiomazine's antipsychotic effect is due to antagonism at dopamine and serotonin type 2 receptors, with greater activity at serotonin 5-HT2 receptors than at dopamine type-2 receptors. This may explain the lack of extrapyramidal effects. Propiomazine does not appear to block dopamine within the tubero-infundibular tract, explaining the lower incidence of hyperprolactinemia than with typical antipsychotic agents or risperidone.

==Side effects==
Rare, serious side effects include convulsions (seizures); difficult or unusually fast breathing; fast or irregular heartbeat or pulse; fever (high); high or low blood pressure; loss of bladder control; muscle stiffness (severe); unusual increase in sweating; unusually pale skin; and unusual tiredness or weakness.

Drowsiness is a usual side effect.

==See also==
* [[Promethazine]]

== References ==
{{Reflist|2}}

{{Hypnotics}}
{{Antipsychotics}}
{{Histamine receptor modulators}}
{{Muscarinic acetylcholine receptor modulators}}
{{Tricyclics}}

[[Category:H1 receptor antagonists]]
[[Category:Hypnotics]]
[[Category:Ketones]]
[[Category:Muscarinic antagonists]]
[[Category:Phenothiazines]]
[[Category:Sedatives]]

{{nervous-system-drug-stub}}